Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Washington University, St. Louis, MO, USA.
Prev Med. 2021 Mar;144:106322. doi: 10.1016/j.ypmed.2020.106322. Epub 2021 Mar 4.
The World Health Organization (WHO) is leading a call to action to eliminate cervical cancer by the end of the century through global implementation of two effective evidence-based preventive interventions: HPV vaccination and cervical screening and management (CSM). Models estimate that without intervention, over the next 50 years 12.2 million new cases of cervical cancer will occur, nearly 60% of which are preventable only through CSM. Given that more than 80% of the cervical cancer occurs in low- and middle-income countries (LMICs), scaling up sustainable CSM programs in these countries is a top priority for achieving the global elimination goals. Multiple technologies have been developed and validated to meet this need. Now it is critical to identify strategies to implement these technologies into complex, adaptive health care delivery systems. As part of the coordinated cervical cancer elimination effort, we applied a systems thinking lens to reflect on our experiences with implementation of HPV-based CSM programs using the WHO health systems framework. While many common health system barriers were identified, the effectiveness of implementation strategies to address them was context dependent; often reflecting differences in stakeholder's belief in the quality of the evidence supporting a CSM algorithm, the appropriateness of the evidence and algorithm to context, and the 'implementability' of the algorithm under realistic assessments of resource availability and constraints. A structured planning process, with early and broad stakeholder engagement, will ensure that shared-decisions in CSM implementation are appropriately aligned with the culture, values, and resource realities of the setting.
世界卫生组织(WHO)呼吁采取行动,通过在全球范围内实施两种有效的基于证据的预防干预措施,即 HPV 疫苗接种和宫颈癌筛查与管理(CSM),在本世纪末消除宫颈癌。模型估计,如果不进行干预,在未来 50 年内,将新增 1220 万例宫颈癌病例,其中近 60%仅通过 CSM 是可以预防的。鉴于超过 80%的宫颈癌发生在中低收入国家(LMICs),在这些国家扩大可持续的 CSM 计划是实现全球消除目标的当务之急。已经开发和验证了多种技术来满足这一需求。现在,关键是要确定将这些技术纳入复杂的适应性医疗保健提供系统的策略。作为协调的宫颈癌消除工作的一部分,我们应用系统思维的视角,根据世卫组织卫生系统框架,反思我们在实施 HPV 为基础的 CSM 计划方面的经验。虽然确定了许多常见的卫生系统障碍,但实施策略的有效性因背景而异;这往往反映了利益相关者对支持 CSM 算法的证据质量、证据和算法对背景的适宜性以及在现实资源可用性和限制下算法的“可实施性”的信念差异。结构化的规划过程,早期和广泛的利益相关者参与,将确保 CSM 实施中的共同决策与环境的文化、价值观和资源现实相适应。